HeartBeam (BEATW) Stock: Why It's Up Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $0.02 as of 12:05 PM ET, +648.39% vs the prior close of $0.00.
- Volume 833.73K shares, 10.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BEATW jumps 648.4% to $0.02 on 10.5x normal volume. Trading at $0.02 (intraday, 12:05 PM ET), +648.39% vs the prior close of $0.00. Day range $0.01–$0.04, opened at $0.29.
BEATW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BEATW jumps 648.4% to $0.02 on 10.5x normal volume
- Trading at $0.02 (intraday, 12:05 PM ET), +648.39% vs the prior close of $0.00. Day range $0.01–$0.04, opened at $0.29.
- Volume was 833.73K shares, 10.5x its 50-day average of 79.26K — unusually heavy trading.
- 52-week range $0.00–$0.04; the current price sits at 63% of that range, 33.7% below the 52-week high.
BEATW bull case vs bear case (from the data)
- Insiders made 25 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $21.02M.
- Share count up 64.2% in a year (dilution).
- High volatility: average daily move of 648.4% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BEATW latest news & SEC filings
Every SEC filing by or about BEATW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 14, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.04M (prior year -$4.97M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.10 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jun 25, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade BEATW
- How much it moves: over the last 20 sessions the average daily move was 648.39% (largest 648.4%). That is a volatile stock.
- Liquidity: about 456.50K shares (≈$10.59K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.02 vs a range of $0.00–$0.04 (63% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Richard Ferrari bought 57,500 shares on Apr 16, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 3, 2026.
- Share count: 56.35M shares outstanding (Aug 11, 2026), +64.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BEATW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.29 | 0.04 | 0.01 | 0.02 | 833.73K |
| Oct 16, 2026 | 0.29 | 0.01 | 0.00 | 0.00 | 79.26K |
About HeartBeam
HeartBeam (BEATW) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SANTA CLARA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1779372.
BEATW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Willem Elfrink | Director | Apr 16, 2026 |
| Richard Ferrari | Director | Apr 24, 2026 |
| Michael R Jaff | Director | Apr 16, 2026 |
| Kenneth Warwick Iii Nelson | Director | Mar 23, 2026 |
| Marga Ortigas-Wedekind | Director | Apr 16, 2026 |
| Mark E Strome | Director | Apr 16, 2026 |
| Branislav Vajdic | President | Jul 24, 2026 |
| Urioste George De | Director | Mar 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Tim Cruickshank | CFO | Jul 24, 2026 |
| Robert Paul Eno | President | Apr 16, 2026 |
| Kenneth Harry Persen | Chief Technology Officer | Jul 24, 2026 |
| Branislav Vajdic | President | Jul 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
BEATW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-21.02M | -0.62 | $-13.99M |
| Dec 31, 2024 | — | $-19.45M | -0.73 | $-14.47M |
| Dec 31, 2023 | — | $-14.64M | -0.72 | $-12.09M |
| Dec 31, 2022 | — | $-12.96M | -1.59 | $-9.95M |
| Dec 31, 2021 | — | $-4.43M | -1.03 | $-3.23M |
Latest balance sheet: total assets $10.64M, total liabilities $2.46M, cash $8.72M (as of Jun 30, 2026).
BEATW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BEATW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.